160 related articles for article (PubMed ID: 38066300)
1. Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer.
Hamelin B; Obradović MMS; Sethi A; Kloc M; Münst S; Beisel C; Eschbach K; Kohler H; Soysal S; Vetter M; Weber WP; Stadler MB; Bentires-Alj M
J Mammary Gland Biol Neoplasia; 2023 Dec; 28(1):26. PubMed ID: 38066300
[TBL] [Abstract][Full Text] [Related]
2. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
[No Abstract] [Full Text] [Related]
3. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
4. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome analysis of heterogeneity in mouse model of metastatic breast cancer.
Ionkina AA; Balderrama-Gutierrez G; Ibanez KJ; Phan SHD; Cortez AN; Mortazavi A; Prescher JA
Breast Cancer Res; 2021 Sep; 23(1):93. PubMed ID: 34579762
[TBL] [Abstract][Full Text] [Related]
6. Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin.
Grasset EM; Dunworth M; Sharma G; Loth M; Tandurella J; Cimino-Mathews A; Gentz M; Bracht S; Haynes M; Fertig EJ; Ewald AJ
Sci Transl Med; 2022 Aug; 14(656):eabn7571. PubMed ID: 35921474
[TBL] [Abstract][Full Text] [Related]
7. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
[TBL] [Abstract][Full Text] [Related]
8. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
9. Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer.
Roca H; Hernandez J; Weidner S; McEachin RC; Fuller D; Sud S; Schumann T; Wilkinson JE; Zaslavsky A; Li H; Maher CA; Daignault-Newton S; Healy PN; Pienta KJ
PLoS One; 2013; 8(10):e76773. PubMed ID: 24124593
[TBL] [Abstract][Full Text] [Related]
10. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b.
Zhou W; Ye XL; Xu J; Cao MG; Fang ZY; Li LY; Guan GH; Liu Q; Qian YH; Xie D
Sci Signal; 2017 Jun; 10(483):. PubMed ID: 28611183
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.
D'Assoro AB; Leontovich A; Amato A; Ayers-Ringler JR; Quatraro C; Hafner K; Jenkins RB; Libra M; Ingle J; Stivala F; Galanis E; Salisbury JL
Int J Oncol; 2010 Nov; 37(5):1167-76. PubMed ID: 20878064
[TBL] [Abstract][Full Text] [Related]
13. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
14. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer.
Bonnomet A; Syne L; Brysse A; Feyereisen E; Thompson EW; Noël A; Foidart JM; Birembaut P; Polette M; Gilles C
Oncogene; 2012 Aug; 31(33):3741-53. PubMed ID: 22120722
[TBL] [Abstract][Full Text] [Related]
15. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
16. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
17. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.
Lawson DA; Bhakta NR; Kessenbrock K; Prummel KD; Yu Y; Takai K; Zhou A; Eyob H; Balakrishnan S; Wang CY; Yaswen P; Goga A; Werb Z
Nature; 2015 Oct; 526(7571):131-5. PubMed ID: 26416748
[TBL] [Abstract][Full Text] [Related]
18. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
[TBL] [Abstract][Full Text] [Related]
19. MLL3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state.
Cui J; Zhang C; Lee JE; Bartholdy BA; Yang D; Liu Y; Erler P; Galbo PM; Hodge DQ; Huangfu D; Zheng D; Ge K; Guo W
Nat Cell Biol; 2023 Jan; 25(1):145-158. PubMed ID: 36604594
[TBL] [Abstract][Full Text] [Related]
20. Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.
Tachtsidis A; Le AV; Blick T; Gunasinghe D; De Sousa E; Waltham M; Dobrovic A; Thompson EW
Clin Exp Metastasis; 2019 Aug; 36(4):393-409. PubMed ID: 31190270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]